BioCatalyst

Alpelisib, Alpelisib matching Placebo, Trastuzumab, Pertuzumab — catalyst calendar

1 verified catalyst event(s) referencing Alpelisib, Alpelisib matching Placebo, Trastuzumab, Pertuzumab, each linked to its official source. Verified as of 2026-10-24.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-26
in 4mo
ESTIMATED
 READOUT
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Ma
Phase 3 · Advanced HER2+Breast Cancer
 NVS NOVARTIS AG Alpelisib, Alpelisib matching Placebo, T ClinicalTrials.gov ↗
✓ Source-checked 2026-10-24
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.